Monocyte Chemoattractant Protein-1 (MCP-1), Not MCP-3, Is the Primary Chemokine Required for Monocyte Recruitment in Mouse Peritonitis Induced with Thioglycollate or Zymosan A

被引:72
作者
Takahashi, Munehisa [1 ]
Galligan, Carole [1 ]
Tessarollo, Lino [2 ]
Yoshimura, Teizo [1 ]
机构
[1] NCI, Lab Mol Immunoregulat Canc & Inflammat Program, Frederick, MD 21702 USA
[2] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
MACROPHAGE-STIMULATING PROTEIN; NF-KAPPA-B; CHEMOTACTIC PROTEIN-3; INFLAMMATORY SITES; CDNA CLONING; RECEPTOR; GENE; EXPRESSION; MICE; TRANSCRIPTION;
D O I
10.4049/jimmunol.0802812
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
MCP-1/CCL2 plays a critical role in monocyte recruitment into sites of immune responses and cancer. However, the role of other MCPs remains unclear. In this study, we generated a novel MCP-1-deficient (designated as MCP-1(Delta/Delta)) mouse model by deleting a 2.3-kb DNA fragment from the mouse genome using the Cre/loxP system. MCP-1 was not produced by LPS-activated MCP-1(Delta/Delta) macrophages; however, the production of MCP-3, coded by the immediate downstream gene, was significantly increased. In contrast, macrophages from another mouse line with a neo-gene cassette in intron 2 produced a significantly lower level of MCP-1 and MCP-3. Decreased MCP-3 production was also detected in previously generated MCP-1-deficient mice in which a neo-gene cassette was inserted in exon 2 (designated as MCP-1 knockout (KO)). Altered MCP-1 and/or MCP-3 production was also observed in vivo in each mouse model in response to i.p. injection of thioglycolate or zymosan. The up- and down-regulation of MCP-3 production in MCP-1(Delta/Delta) and MCP-1 KO mice, respectively, provided us with a unique opportunity to evaluate the role for MCP-3. Despite the increased MCP-3 production in MCP-1(Delta/Delta) mice, thioglycolate- or zymosan-induced monocyte/macrophage accumulation was still reduced by similar to 50% compared with wild-type mice, similar to the reduction detected in MCP-1 KO mice. Thus, up-regulated MCP-3 production did not compensate for the loss of MCP-1, and MCP-3 appears to be a less effective mediator of monocyte recruitment than MCP-1. Our results also indicate the presence of other mediators regulating the recruitment of monocytes in these models. The Journal of Immunology, 2009, 183: 3463-3471.
引用
收藏
页码:3463 / 3471
页数:9
相关论文
共 50 条
  • [21] Association between new onset diabetic retinopathy and monocyte chemoattractant protein-1 (MCP-1) polymorphism in Japanese type 2 diabetes
    Ninomiya, Hiroyo
    Katakami, Naoto
    Osonoi, Takeshi
    Saitou, Miyoko
    Yamamoto, Yuichi
    Takahara, Mitsuyoshi
    Kawamori, Dan
    Matsuoka, Taka-aki
    Yamasaki, Yoshimitsu
    Shimomura, Iichiro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 108 (03) : E35 - E37
  • [22] Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines
    Thibeault, I
    Laflamme, N
    Rivest, S
    JOURNAL OF COMPARATIVE NEUROLOGY, 2001, 434 (04) : 461 - 477
  • [23] Significant Therapeutic Effects of Adult Human Neural Stem Cells for Spinal Cord Injury Are Mediated by Monocyte Chemoattractant Protein-1 (MCP-1)
    Kim, Chung Kwon
    Won, Jeong-Seob
    An, Jae Yeol
    Lee, Ho Jin
    Nam, Ah-Jin
    Nam, Hyun
    Lee, Ji Yeoun
    Lee, Kyung-Hoon
    Lee, Sun-Ho
    Joo, Kyeung Min
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [24] Osteoblastic monocyte chemoattractant protein-1 (MCP-1) mediation of parathyroid hormone's anabolic actions in bone implicates TGF-β signaling
    Siddiqui, Jawed A.
    Le Henaff, Carole
    Johnson, Joshua
    He, Zhiming
    Rifkin, Daniel B.
    Partridge, Nicola C.
    BONE, 2021, 143
  • [25] Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells
    Dagouassat, Maylis
    Suffee, Nadine
    Hlawaty, Hanna
    Haddad, Oualid
    Charni, Faten
    Laguillier, Christelle
    Vassy, Roger
    Martin, Loic
    Schischmanoff, Pierre-Olivier
    Gattegno, Liliane
    Oudar, Olivier
    Sutton, Angela
    Charnaux, Nathalie
    INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (05) : 1095 - 1108
  • [26] Monocytes and monocyte chemoattractant protein 1 (MCP-1) as early predictors of disease outcome in patients with cerebral ischemic stroke
    Bonifacic, David
    Toplak, Adrian
    Benjak, Indira
    Tokmadzic, Vlatka Sotosek
    Lekic, Andrica
    Kucic, Natalia
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 (1-2) : 20 - 27
  • [27] Monocyte chemoattractant protein 1 (MCP-1/CCL2) contributes to thymus atrophy in acute myeloid leukemia
    Driss, Virginie
    Quesnel, Bruno
    Brinster, Carine
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (02) : 396 - 406
  • [28] Monocyte Chemotactic Protein-1 (MCP-1) in Patients with Chronic Schistosomiasis Mansoni: Evidences of Subclinical Renal Inflammation
    Hanemann, Ana Lucia P.
    Liborio, Alexandre B.
    Daher, Elizabeth F.
    Martins, Alice Maria C.
    Pinheiro, Marta Cristhiany C.
    Sousa, Mariana S.
    Bezerra, Fernando Schemelzer M.
    PLOS ONE, 2013, 8 (11):
  • [29] Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy
    Wyler, Stephanie L.
    D'Ingillo, Shawna L.
    Lamb, Cheri L.
    Mitchell, Kristen A.
    JOURNAL OF INFLAMMATION-LONDON, 2016, 13
  • [30] Association of monocyte chemoattractant protein-1 (MCP-1)2518A/G polymorphism with proliferative diabetic retinopathy in northern Chinese type 2 diabetes
    Dong, Li
    Lv, Xiao Ying
    Wang, Bin Jie
    Wang, Ye Qing
    Mu, Hua
    Feng, Zhuo Lei
    Liu, Ping
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (12) : 1921 - 1926